Bibliographie (2530)
M-A | Combination therapy with long-acting bronchodilators and risk of adverse cardiovascular events in patients with COPD.
jeudi, 29 septembre 2022 13:39 Écrit par Zouhair SouissiCombination therapy with long-acting bronchodilators and the risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis – European Respiratory Journal (link to abstract – $ for full-text)
The post M-A | Combination therapy with long-acting bronchodilators and risk of adverse cardiovascular events in patients with COPD. appeared first on Links Medicus.
M-A | Optimal management, prevalence, and clinical behavior of saddle pulmonary embolism.
jeudi, 29 septembre 2022 13:39 Écrit par Zouhair SouissiOptimal management, prevalence, and clinical behavior of saddle pulmonary embolism: A systematic review and meta-analysis – Thrombosis Research Commentary on Twitter #review Despite its ominous radiologic appearance, clinical behavior and mortality from #saddle pulmonary embolism are comparable to other pulmonary embolism types. https://t.co/NpLs77f5MT pic.twitter.com/2uZ4jhY32G — Thrombosis Research (@ThrombosisRese1) September 5, 2022
The post M-A | Optimal management, prevalence, and clinical behavior of saddle pulmonary embolism. appeared first on Links Medicus.
M-A of randomized trials | High-flow nasal cannula oxygen therapy vs. non-invasive ventilation for patients with acute exacerbation of COPD after extubation.
mercredi, 21 septembre 2022 22:44 Écrit par Zouhair SouissiHigh-Flow Nasal Cannula Oxygen Therapy versus Non-Invasive Ventilation for AECOPD Patients After Extubation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials – International Journal of Chronic Obstructive Pulmonary Disease
The post M-A of randomized trials | High-flow nasal cannula oxygen therapy vs. non-invasive ventilation for patients with acute exacerbation of COPD after extubation. appeared first on Links Medicus.
The Lancet Commission | Towards the elimination of chronic obstructive pulmonary disease.
mercredi, 21 septembre 2022 22:44 Écrit par Zouhair SouissiHomepage: Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission – The Lancet Commission: Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission Editorial: COPD: from an end-stage disease to lifelong lung health Invited Commentary: Classification of COPD: fostering prevention and precision medicine in the Lancet Commission on COPD Commentary: Proposed classification of COPD according […]
The post The Lancet Commission | Towards the elimination of chronic obstructive pulmonary disease. appeared first on Links Medicus.
M-A of randomized trials | In patients hospitalized with community-acquired pneumonia, corticosteroids reduce the need for mechanical ventilation without significant effects on mortality, treatment failure, or adverse events.
mercredi, 21 septembre 2022 22:44 Écrit par Zouhair SouissiEffect of corticosteroids on mortality and clinical cure in community-acquired pneumonia: A systematic review, meta-analysis, and meta-regression of randomized control trials – CHEST Journal (link to abstract – $ for full-text) Related: Corticosteroids for CAP, influenza and COVID-19: when, how and benefits or harm? – European Respiratory Review
The post M-A of randomized trials | In patients hospitalized with community-acquired pneumonia, corticosteroids reduce the need for mechanical ventilation without significant effects on mortality, treatment failure, or adverse events. appeared first on Links Medicus.
RCT | Dexamethasone is not effective for the treatment of dyspnea in patients with cancer and increases the risk of adverse events.
mercredi, 21 septembre 2022 22:44 Écrit par Zouhair SouissiEffect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial – The Lancet Oncology (free for a limited period) Commentary on Twitter Our phase III randomized study, published in Lancet Oncology today, showed high-dose steroid didn’t improve SOB and should not be used routinely in pts with lung […]
The post RCT | Dexamethasone is not effective for the treatment of dyspnea in patients with cancer and increases the risk of adverse events. appeared first on Links Medicus.
RCT | A double-dose influenza vaccination during hospitalization for acute coronary syndrome did not improve outcomes compared to standard-dose outpatient vaccination.
mercredi, 21 septembre 2022 22:44 Écrit par Zouhair SouissiInfluenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial – European Heart Journal Commentary on Twitter In the VIP-ACS trial, among patients hospitalised with an ACS, double dose influenza vaccination before discharge does not reduce cardiovascular and pulmonary outcomes compared with standard dose vaccination ?https://t.co/L9e7MXWfWV#EHJ #ESCCongress @ehj_ed @rladeiraslopes pic.twitter.com/95o50krrwm — European Society of […]
The post RCT | A double-dose influenza vaccination during hospitalization for acute coronary syndrome did not improve outcomes compared to standard-dose outpatient vaccination. appeared first on Links Medicus.
RCT | Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19.
mercredi, 21 septembre 2022 22:44 Écrit par Zouhair SouissiAnti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial – The Lancet Respiratory Medicine Commentaries on Twitter Interesting results in the #PANAMO trial of vilobelimab, an anti-C5a antibody, in critically ill ICU patients w/ COVID19. People on MV (n=386) randomized to […]
The post RCT | Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19. appeared first on Links Medicus.
RCT | Dipeptidyl peptidase-1 inhibition does not improve outcomes in patients hospitalized with COVID-19.
mercredi, 21 septembre 2022 22:44 Écrit par Zouhair SouissiDipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial – The Lancet Respiratory Medicine Commentary on Twitter NEW Research—Brensocatib treatment did not improve clinical status at day 29 in patients hospitalised with #COVID19 Being presented at #ERSCongress, ALERT 3 session, Sept 5 from 13:15 BST From @profjdchalmers, @keirholly, […]
The post RCT | Dipeptidyl peptidase-1 inhibition does not improve outcomes in patients hospitalized with COVID-19. appeared first on Links Medicus.
Pulmonary artery denervation for pulmonary arterial hypertension: a sham-controlled randomized trial.
mercredi, 21 septembre 2022 22:44 Écrit par Zouhair SouissiPulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomized Trial – JACC: Cardiovascular Interventions Commentaries: Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test – TCTMD Pulmonary Artery Denervation for Pulmonary Arterial Hypertension – PADN-CFDA – American College of Cardiology Commentary on Twitter #TCT2022 #JACCINT LBCT SimPub: PADN-CFDA trial included 128 pts […]
The post Pulmonary artery denervation for pulmonary arterial hypertension: a sham-controlled randomized trial. appeared first on Links Medicus.
